| Model Number |
TV-IL1412120-J |
| Medical Device Problem Codes |
Complete Blockage (1094); Insufficient Device Problem Information (3190)
|
| Health Effect - Clinical Codes |
Failure of Implant (1924); Obstruction/Occlusion (2422)
|
| Date of Event |
10/07/2021
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
The devices involved in this event will not be returned for evaluation and remain implanted in the patient.Patient medical records and imaging studies will be requested for further evaluation by a clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
|
| |
|
Event or Problem Description
|
|
The patient was initially treated for an abdominal aortic aneurysm (aaa) with the ovation ix abdominal aortic aneurysm stent graft system.Approximately three (3) years post initial procedure limb occlusion was identified.Reintervention was completed by declotting the limb and implanting an additional ovation ix iliac limb.There was also proximal stenosis that was ballooned using a 10 x 4 pta balloon.The patient was reported to be doing well.
|
| |
|
Event or Problem Description
|
|
The patient was initially treated for an abdominal aortic aneurysm (aaa) with the ovation ix abdominal aortic aneurysm stent graft system.Approximately three (3) years post initial procedure limb occlusion was identified.Reintervention was completed by declotting the limb and implanting an additional ovation ix iliac limb.There was also proximal stenosis that was ballooned using a 10x4 pta balloon.The patient was reported to be doing well.Additional information: an internal clinical assessment determined that there was evidence to reasonably suggest a type 2 endoleak (non-device related) of the lumbar artery occurred that was not included in the event as reported.The type 2 endoleak was discovered during review of the 1 month post implant ct scan.
|
| |
|
Additional Manufacturer Narrative
|
|
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.The review confirms there were no manufacturing or processing non-conformities identified that would contribute to the reported adverse event/incident.An evaluation of the device could not be completed.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows that the right iliac limb occlusion is confirmed from the medical records.This is consistent with the reported adverse event/incident.The clinical evaluation also shows reasonable evidence to suggest a type 2 endoleak of the lumbar artery occurred that was not included in the event as reported.There was a total occlusion of the proximal right common iliac artery at the index procedure.It is unclear if this contributed to the reported event.There were thickened calcifications in the iliac arteries (cautionary product use condition).Procedure related harms, device, user, procedure or anatomy relatedness of this complaint could not be determined with the medical records available for review.The final patient status was reported to be doing well.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.
|
| |
|
Search Alerts/Recalls
|